Arkadios Wealth Advisors Dr Reddys Laboratories LTD Transaction History
Arkadios Wealth Advisors
- $1.71 Billion
- Q4 2024
Shares
4 transactions
Others Institutions Holding RDY
# of Institutions
258Shares Held
38.2MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$159 Million0.35% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa2.47MShares$34.3 Million0.02% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31.1 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$27.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.1 Million0.25% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...